Name: Portfolio expansion in biopharmaceuticals
Uploaded: 2018-10-29T00:00:00+00:00
Duration: 3 min 18 s
Description: NutritionInsight spoke with Kelsey Achenbach of Roquette at CPhI 2018 in Madrid about the company's portfolio expansion in biopharmaceuticals. This year, Roquette’s featured products included the newly launched low endotoxin Kleptose BioPharma HPB/HP grades of hydroxypropyl β-cyclodextrins for protein stability, as well as Dextrose Anhydrous BioPharma for cell culture solutions.

Industry news
Industry news
All news
Business
Food ingredients
New product development
Packaging & processing
Personal care & cosmetics
Policy & regulation
Research & science
Tech & innovation
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap
Category news
Category news
Bone & joint health
Brain & mental health
Child nutrition
Delivery formats
Food security
Gut health
Heart health
Immunity
Infant nutrition
Men's health
Nutraceuticals
Oral & eye health
Personalized nutrition
Pet nutrition
Skin & beauty
Sports nutrition
Supplements
Weight management
Women's health
Reports
Reports
Key interviews
Special reports
Technical papers
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap
Key trends
Key trends
All key trends
Trend analysis
Nutrition focus
Product innovation
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap
Multimedia
Multimedia
All multimedia
Videos
Webinars
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap
Journal
Journal
Access all Editions
Advertising options
Subscribe now
Editorial enquiries
Latest editions
Souped-Up Flavors
Ready Meal Remix
Refreshment with Benefits
Redefining Indulgence
Events
Events
Event listing
Event previews
Event reviews
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap
Suppliers
Suppliers
Supplier profiles
Trending now
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
Nestlé brand launches infant gut health guide to close parents’ information gap

Novonesis Human Health Biosolutions banner featuring a young girl beside the message, “From strain to solution—helping you go seamlessly from idea to market.”

Home

Videos

Portfolio expansion ...

Portfolio expansion in biopharmaceuticals

29 Oct 2018 | Roquette

NutritionInsight spoke with Kelsey Achenbach of Roquette at CPhI 2018 in Madrid about the company's portfolio expansion in biopharmaceuticals. This year, Roquette’s featured products included the newly launched low endotoxin Kleptose BioPharma HPB/HP grades of hydroxypropyl β-cyclodextrins for protein stability, as well as Dextrose Anhydrous BioPharma for cell culture solutions.

More videos

Video04:53

Hilmar: Tight supply and growing demand boost US whey protein competitiveness in Europe

Marina Crocker, senior director of Product Category and Marketing at Hilmar, highlights how a tight global supply and rising demand have improved the competitiveness of US whey proteins in Europe. As a result, the company debuted...

Dr. Torsten Grothe, Mibelle Biochemistry

Video05:11

Mibelle Biochemistry: Water-soluble collagen booster expands skin health from within applications

Dr. Torsten Grothe, head of Food & Health at Mibelle Biochemistry, presents application potential and clinical research findings on a new water-soluble version of the company’s plant-based collagen-booster, DracoBelle Nu. Studies...

Video09:21

Kanaka Probiotics: KABP-051 and the future of weight management and psychobiotics

Kaneka Probiotics and AB-Biotics’ latest clinical research on probiotic Lactiplantibacillus plantarum KABP-051 observed modest weight loss alongside improvements mood and energy over 12 weeks, without a diet or exercise plan....

Leena Uabumrungjit, Thai Union Ingredients

Video04:48

Vitafoods Europe 2026: Thai Union Ingredients’ upcycled marine supplement solutions

Leena Uabumrungjit, the senior director at Thai Union Ingredients, spoke with us about the company’s marine ingredient portfolio, which spans omega-3 oils, marine collagen, and tuna-derived calcium. She also spotlighted the...

Bone And Joint Health, Delivery Formats, DolCas Biotech, KG Rao, Marine Collagen, Marine Collagen Tripeptides, Morikol, New Product Development, Nutraceuticals, Skin And Beauty, Sports Nutrition, Supp

Video11:29

DolCas Biotech: CEO highlights Morikol marine collagen science and delivery format R&D

KG Rao, CEO of DolCas Biotech, dives deeper into the science behind Morikol, its marine collagen tripeptide ingredient. He also shares market insights on marine collagen and highlights DolCas Biotech’s R&D strategy, which focuses...

Video05:32

Vitafoods Europe 2026: Sabinsa’s ImmunoSpore postbiotic targets gut-immune health

Sabinsa’s CEO, Shaheen Majeed, introduced the company’s latest ingredient ImmunoSpore. The heat-inactivated postbiotic derived from Lactospore supports intestinal barrier function, gut-immune signaling, and mucosal health. At the...